← Back to Search

N/A

Antibiotic Use Reports for Infections (VAST Trial)

N/A

Waitlist Available

Led By Charlesnika Tyon Evans, PhD MPH BS

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

VA medical centers without local ID expertise that pair with an ID-expert from another VA medical center.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2.25 years

Awards & highlights

VAST Trial Summary

This trial will test whether providing quarterly reports on a facility's antibiotic usage will help reduce overall antibiotic use.

Who is the study for?

This trial is for VA medical centers lacking local infectious disease (ID) expertise. These centers will partner with an ID expert from another VA facility to implement the program.Check my eligibility

What is being tested?

The study tests if quarterly reports on antibiotic use can improve a telehealth program called VAST, which aims to reduce unnecessary antibiotic prescriptions at rural VA medical centers by connecting them with distant ID experts.See study design

What are the potential side effects?

Since this trial focuses on implementing a stewardship program rather than direct patient interventions, it does not involve side effects in the traditional sense of medication or treatment.

VAST Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

VAST Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2.25 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2.25 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2.25 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Days of Antibiotic Therapy / 1000 Bed Days of Care

Secondary outcome measures

Antibiotic Starts

Rate of broad-spectrum antibiotics

VAST Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: VAST+Experimental Treatment1 Intervention

Sites that implement the VAST augmented by quarterly facility-level Antibiotic Use Reports (VAST+).

Group II: VAST -Active Control1 Intervention

to sites that implement the VAST and do NOT receive a quarterly facility-level Antibiotic Use Reports (VAST-).

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor

1,609 Previous Clinical Trials

3,306,595 Total Patients Enrolled

5 Trials studying Pneumonia

993 Patients Enrolled for Pneumonia

Charlesnika Tyon Evans, PhD MPH BSPrincipal InvestigatorEdward Hines Jr. VA Hospital, Hines, IL

Robin Lynn Paige Jump, MD PhDPrincipal InvestigatorVA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA

Media Library

Videoconference Antimicrobial Stewardship Team (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05319561 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor presently accepting participants?

"Data hosted on clinicaltrials.gov reveals that this research is not presently taking applications from prospective patients. Although the study was initially posted in March 28th 2022, the last update occurred on April 11th 2022, suggesting it has been put on hold. Nevertheless, 944 other trials are still open to enrollment at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team

2022. "Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05319561.

All > Uti